SEC Form 4 · accession 0001562180-19-001069
VAPOTHERM INC · VAPO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael McQueen
Officer — Officer
Period of report
Jan 17, 2019
Accepted (ET)
Feb 19, 2019 · 9:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001253176
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 61,184 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock AwardF1,F2 | — | Jan 17, 2019 | A | 2,898 | A | — | — | Common Stock | 2,898 | 2,898 | D |
Explanation of responses
- F1Each RSA represents a contingent right to receive one share of VAPO common stock.
- F2This RSA is eligible to vest as to 25% of the underlying shares on January 17, 2019 and thereafter, as to the remaining 75% of underlying shares, in 36 equal monthly installments. Subject to the terms of the Company's equity incentive plan.